Vascular Behçet syndrome: from pathogenesis to treatment
A Bettiol, F Alibaz-Oner, H Direskeneli… - Nature Reviews …, 2023 - nature.com
Behçet syndrome is a rare, chronic inflammatory disease of unknown aetiopathogenesis,
most commonly presenting with mucocutaneous and ocular manifestations. Vascular …
most commonly presenting with mucocutaneous and ocular manifestations. Vascular …
Behçet's disease: new insights into pathophysiology, clinical features and treatment options
Behçet's disease (BD) is a rare systemic vasculitis characterized by oral aphthous ulcers,
genital ulcers, ocular lesions and other systemic manifestations. BD occurs most frequently …
genital ulcers, ocular lesions and other systemic manifestations. BD occurs most frequently …
Risk factors, clinical features and treatment of Behçet's disease uveitis
Z Zhong, G Su, P Yang - Progress in Retinal and Eye Research, 2023 - Elsevier
Behçet's disease is a systemic vasculitis frequently associated with intraocular inflammation.
Recent findings identified independent clinical clusters in Behçet's disease, each involving …
Recent findings identified independent clinical clusters in Behçet's disease, each involving …
Behçet's Syndrome
Behçet’s Syndrome | New England Journal of Medicine Skip to main content Access provided
byKuopion Yliopistollinen Sairaala The New England Journal of Medicine homepage Advanced …
byKuopion Yliopistollinen Sairaala The New England Journal of Medicine homepage Advanced …
The relationship between technology readiness and smart city performance in Dubai
Unlike any other city, Dubai is proactive in foreseeing the congestion issue popular among
the cities. Therefore, the government supported the implementation of the smart city in …
the cities. Therefore, the government supported the implementation of the smart city in …
[HTML][HTML] Trial of apremilast for oral ulcers in Behçet's syndrome
Background The small-molecule phosphodiesterase 4 inhibitor apremilast modulates
cytokines that are up-regulated in Behçet's syndrome. In a phase 2 trial involving patients …
cytokines that are up-regulated in Behçet's syndrome. In a phase 2 trial involving patients …
Vascular Behçet's syndrome: an update
G Emmi, A Bettiol, E Silvestri, G Di Scala… - Internal and emergency …, 2019 - Springer
Behçet's syndrome (BS) is a complex vasculitis, characterised by peculiar histological,
pathogenetic and clinical features. Superficial venous thrombosis (SVT) and deep vein …
pathogenetic and clinical features. Superficial venous thrombosis (SVT) and deep vein …
[HTML][HTML] New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review
JT Rosenbaum, B Bodaghi, C Couto, M Zierhut… - Seminars in arthritis and …, 2019 - Elsevier
Background Non-infectious uveitis (NIU) is an immune-mediated disease with clinical
symptoms such as eye pain, redness, floaters, and light sensitivity. NIU is one of the leading …
symptoms such as eye pain, redness, floaters, and light sensitivity. NIU is one of the leading …
Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis
P Emery, J Rondon, J Parrino, Y Lin… - …, 2019 - academic.oup.com
Objective Safety and efficacy of mAbs blocking the IL-6 receptor have been established in
RA. This is the first analysis examining safety and tolerability of sarilumab and tocilizumab …
RA. This is the first analysis examining safety and tolerability of sarilumab and tocilizumab …
A cutoff value for the Systemic Immune‐Inflammation Index in determining activity of Behçet disease
E Tanacan, D Dinçer, FG Erdogan… - Clinical and …, 2021 - academic.oup.com
Background Behçet disease (BD) is an immune‐mediated vasculitis‐like syndrome
characterized by recurrent aphthous lesions and various systemic manifestations …
characterized by recurrent aphthous lesions and various systemic manifestations …